Biosimilars Access and Affordability Act

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 5459 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 5459 To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES December 9, 2024 Mrs. Blackburn introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Biosimilars Access and Affordability Act''. SEC. 2. CHANGE OF WHEN BIOSIMILARS ARE ELIGIBLE FOR PRICE NEGOTIATIONS. (a) In General.--Section 1192 of the Social Security Act (42 U.S.C. 1320f-1) is amended-- (1) in subsection (c)-- (A) in paragraph (1)…